Growth Metrics

Catalyst Pharmaceuticals (CPRX) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 29.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 29.36%
Dec 31, 2025 43.24%
Sep 30, 2025 40.26%
Jun 30, 2025 55.43%
Mar 31, 2025 45.40%
Dec 31, 2024 52.02%
Sep 30, 2024 43.03%
Jun 30, 2024 42.67%
Mar 31, 2024 73.80%
Dec 31, 2023 42.49%
Sep 30, 2023 37.11%
Jun 30, 2023 22.50%
Mar 31, 2023 23.94%
Dec 31, 2022 18.77%
Sep 30, 2022 35.99%
Jun 30, 2022 29.80%
Mar 31, 2022 26.80%
Dec 31, 2021 12.65%
Sep 30, 2021 25.87%
Jun 30, 2021 24.24%
Mar 31, 2021 17.38%
Dec 31, 2020 44.64%
Sep 30, 2020 40.78%
Jun 30, 2020 41.10%
Mar 31, 2020 26.29%
Dec 31, 2019 33.00%
Sep 30, 2019 15.36%
Jun 30, 2019 37.31%
Mar 31, 2019 26.79%
Dec 31, 2018 21.34%
Sep 30, 2018 31.85%
Jun 30, 2018 29.57%
Mar 31, 2018 45.64%
Dec 31, 2017 19.06%
Sep 30, 2017 6.01%
Jun 30, 2017 204.71%
Mar 31, 2017 219.47%
Dec 31, 2016 125.61%
Sep 30, 2016 125.09%
Jun 30, 2016 99.66%
Mar 31, 2016 122.19%
Dec 31, 2015 41.30%
Sep 30, 2015 93.60%
Jun 30, 2015 100.59%
Mar 31, 2015 91.05%
Dec 31, 2014 4.94%
Sep 30, 2014 108.60%
Jun 30, 2014 -29.74%
Mar 31, 2014 -24.50%
Dec 31, 2013 -44.28%
Sep 30, 2013 9.06%